☒
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 |
Nevada | 26-1394771 | |||||||
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
100 Commerce Drive | ||||||||
Loveland, Ohio 45140
|
(513) 360-4704
|
|||||||
(Address of principal executive offices) | (Registrant’s telephone number) |
Title of each Class: | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Common Stock, $0.001 par value per share | WKHS | The NASDAQ Capital Market |
Large accelerated filer | ☐ | Accelerated filer |
☒
|
|||||||||||
Non-accelerated filer | ☐ | Smaller reporting company |
☒
|
|||||||||||
Emerging growth company | ☐ |
Country | Serial Number | Application Date | Patent Number | Issue/Grant Date | Expiration Date | Title | ||||||||||||||||||||||||||||||||
United States | 13/283,663 | 10/28/2011 | 8,541,915 | 9/24/2013 | 12/16/2031 | Drive module and manifold for electric motor drive assembly | ||||||||||||||||||||||||||||||||
Canada | 2,523,653 | 10/17/2005 | 2,523,653 | 12/22/2009 | 10/17/2025 | Vehicle chassis assembly | ||||||||||||||||||||||||||||||||
United States | 11/252,220 | 10/17/2005 | 7,717,464 | 5/18/2010 | 9/6/2026 | Vehicle chassis assembly | ||||||||||||||||||||||||||||||||
United States | 11/252,219 | 10/17/2005 | 7,559,578 | 7/14/2009 | 9/6/2026 | Vehicle chassis assembly | ||||||||||||||||||||||||||||||||
United States | 29/243,074 | 11/18/2005 | D561,078 | 2/5/2008 | 2/5/2022 | Vehicle header | ||||||||||||||||||||||||||||||||
United States | 29/243,129 | 11/18/2005 | D561,079 | 2/5/2008 | 2/5/2022 | Vehicle header | ||||||||||||||||||||||||||||||||
United States | 14/606,497 | 1/27/2015 | 9,481,256 | 11/1/2016 | 5/3/2035 | Onboard generator drive system for electric vehicles | ||||||||||||||||||||||||||||||||
United States | 14/989,870 | 1/7/2016 | 9,915,956 | 3/13/2018 | 6/24/2036 | Package delivery by means of an automated multicopter UAS/UAV dispatched from a conventional delivery vehicle | ||||||||||||||||||||||||||||||||
United States | 15/915,144 | 3/8/2018 | Package delivery by means of an automated multicopter UAS/UAV dispatched from a conventional delivery vehicle (1) | |||||||||||||||||||||||||||||||||||
United States | 62/957,577 | 1/6/2020 | Systems and Methods for Manufacturing Land Vehicles | |||||||||||||||||||||||||||||||||||
United States | 62/959,548 | 1/10/2020 | Electric Delivery Truck Control System for Electric Power Management | |||||||||||||||||||||||||||||||||||
United States | 29/719,591 | 1/6/2020 | Design Application that covering the electric delivery truck |
Location |
Approximate Size (Building) in
Square Feet |
Primary Use | Owned, Lease or Licensed |
Lease/License
Expiration Date (if applicable) |
||||||||||||||||||||||
Loveland, Ohio | 45,000 | Administration, Research and Development, Manufacturing | Owned | N/A | ||||||||||||||||||||||
Union City, Indiana | 250,000 | Manufacturing | Owned | N/A | ||||||||||||||||||||||
Loveland, Ohio | 5,810 | Administration | Lease | Monthly |
Plan |
Number of Securities to be
Issued upon Exercise of Outstanding Options and Rights |
Weighted Average Exercise
Price of Outstanding Options |
Number of Securities
Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities reflected in first column) |
|||||||||||||||||
Equity Compensation Plans approved by security holders - 2015
Stock Incentive Plan
|
197,500 | $ | 4.41 | — | ||||||||||||||||
Equity Compensation Plans approved by security holders - 2016
Stock Incentive Plan
|
455,000 | $ | 6.59 | — | ||||||||||||||||
Equity Compensation Plans approved by security holders - 2017
Stock Incentive Plan
|
2,672,500 | $ | 1.64 | 2,235,000 | ||||||||||||||||
Equity Compensation Plans approved by security holders - 2019
Stock Incentive Plan
|
400,000 | $ | 0.93 | 5,794,778 | ||||||||||||||||
3,725,000 | 8,029,778 |
YEARS ENDED DECEMBER 31, | 2019 | 2018 | 2017 | |||||||||||||||||
OPERATING SUMMARY | ||||||||||||||||||||
Net sales | $ | 376,562 | $ | 763,173 | $ | 10,038,460 | ||||||||||||||
Net loss | $ | (37,162,827) | $ | (36,502,316) | $ | (41,216,788) | ||||||||||||||
Net loss attributable to common stockholders per share –
basic and diluted |
$ | (0.58) | $ | (0.74) | $ | (1.06) | ||||||||||||||
Weighted average number of common shares outstanding | 64,314,756 | 50,377,909 | 38,755,796 | |||||||||||||||||
FINANCIAL POSITION SUMMARY | ||||||||||||||||||||
Total assets | $ | 50,673,829 | $ | 11,804,773 | $ | 16,504,293 | ||||||||||||||
Long-term debt and mandatory redeemable Series B preferred stock | $ | 19,142,908 | $ | 8,312,079 | $ | 1,709,881 | ||||||||||||||
Convertible Note, at fair value | $ | 39,020,000 | $ | — | $ | — | ||||||||||||||
Cash dividends per common share | $ | — | $ | — | $ | — |
Years Ended
December 31, |
|||||||||||||||||
2019 | 2018 | ||||||||||||||||
Net sales | $ | 376,562 | 763,173 | ||||||||||||||
Cost of sales | 5,752,700 | 7,981,413 | |||||||||||||||
Warranty expense | 92,191 | 7,972,152 | |||||||||||||||
Gross loss | (5,468,329) | (15,190,392) | |||||||||||||||
Operating expenses | |||||||||||||||||
Selling, general and administrative | 10,199,534 | 11,485,482 | |||||||||||||||
Research and development | 8,199,074 | 7,391,693 | |||||||||||||||
Total operating expenses | 18,398,608 | 18,877,175 | |||||||||||||||
Other income | 15,849,800 | — | |||||||||||||||
Loss from operations | (8,017,137) | (34,067,567) | |||||||||||||||
Interest expense, net | 29,145,690 | 2,434,749 | |||||||||||||||
Loss before provision for income taxes | (37,162,827) | (36,502,316) | |||||||||||||||
Provision for income taxes | — | — | |||||||||||||||
Net loss | $ | (37,162,827) | $ | (36,502,316) |
Years Ended December 31, | |||||||||||||||||
2019
|
2018
|
||||||||||||||||
Technology licensing income | $ | 12,194,800 | $ | — | |||||||||||||
Gain on divestiture | 3,655,000 | — | |||||||||||||||
Total other income | $ | 15,849,800 | $ | — |
Years Ended
December 31, |
|||||||||||||||||
2019 | 2018 | ||||||||||||||||
Contractual interest expense | $ | 4,673,979 | $ | 520,130 | |||||||||||||
Amortization of discount and debt issuance costs | 1,922,164 | 2,348,289 | |||||||||||||||
Loss on extinguishment of debt | 6,079,000 | 2,249,800 | |||||||||||||||
Change in fair value of warrant liability | 15,369,253 | (2,683,470) | |||||||||||||||
Change in fair value of Convertible Note | 981,728 | — | |||||||||||||||
Other | 119,566 | — | |||||||||||||||
Total interest expense, net | $ | 29,145,690 | $ | 2,434,749 |
For the Years Ended December 31, | |||||||||||||||||
2019 | 2018 | ||||||||||||||||
Net cash used in operating activities | $ | (36,871,677) | $ | (21,754,133) | |||||||||||||
Net cash provided by (used in) investing activities | 1,654,502 | (18,422) | |||||||||||||||
Net cash provided by financing activities | 58,572,841 | 19,215,828 |
Financial Statements: | |||||
December 31, | |||||||||||||||||
2019 | 2018 | ||||||||||||||||
Assets | |||||||||||||||||
Current assets: | |||||||||||||||||
Cash and cash equivalents | $ | 23,868,416 | $ | 1,512,750 | |||||||||||||
Restricted cash held in escrow | 1,000,000 | — | |||||||||||||||
Accounts receivable, less allowance for doubtful accounts of $0 at December 31, 2019 and 2018
|
7,921 | — | |||||||||||||||
Lease receivable, current | 33,100 | 48,271 | |||||||||||||||
Inventory, net | 1,798,146 | 2,533,616 | |||||||||||||||
Prepaid expenses and deposits | 4,812,088 | 2,274,595 | |||||||||||||||
Total current assets | 31,519,671 | 6,369,232 | |||||||||||||||
Property, plant and equipment, net | 6,830,181 | 5,237,451 | |||||||||||||||
Investment in LMC | 12,194,800 | — | |||||||||||||||
Lease receivable, long-term | 129,177 | 198,090 | |||||||||||||||
Total Assets | $ | 50,673,829 | $ | 11,804,773 | |||||||||||||
Liabilities and Stockholders’ Deficit | |||||||||||||||||
Current liabilities: | |||||||||||||||||
Accounts payable | $ | 1,678,983 | $ | 4,340,463 | |||||||||||||
Accrued liabilities | 3,105,184 | 3,946,386 | |||||||||||||||
Warranty liability | 6,001,864 | 7,058,769 | |||||||||||||||
Warrant liability | 16,335,000 | 1,822,819 | |||||||||||||||
Customer deposits | 303,000 | 406,000 | |||||||||||||||
Duke financing obligation | — | 1,340,700 | |||||||||||||||
Current portion of Convertible Note, at fair value | 19,620,000 | — | |||||||||||||||
Total current liabilities | 47,044,031 | 18,915,137 | |||||||||||||||
Long-term debt | — | 8,312,079 | |||||||||||||||
Convertible Note, at fair value | 19,400,000 | — | |||||||||||||||
Mandatory redeemable Series B preferred stock | 19,142,908 | — | |||||||||||||||
Commitments and contingencies | |||||||||||||||||
Stockholders’ deficit: | |||||||||||||||||
Series A preferred stock, par value of $0.001 per share 75,000,000 shares authorized, 0 shares issued and outstanding at December 31, 2019 and 2018
|
— | — | |||||||||||||||
Common stock, par value of $0.001 per share 250,000,000 shares authorized, 67,105,000 shares issued and outstanding at December 31, 2019 and 58,270,934 shares issued and outstanding at December 31, 2018
|
67,105 | 58,271 | |||||||||||||||
Additional paid-in capital | 143,826,315 | 126,076,782 | |||||||||||||||
Accumulated deficit | (178,806,530) | (141,557,496) | |||||||||||||||
Total stockholders' deficit | (34,913,110) | (15,422,443) | |||||||||||||||
Total Liabilities and Stockholders' Deficit | $ | 50,673,829 | $ | 11,804,773 |
For the Years Ended December 31, | |||||||||||||||||
2019 | 2018 | ||||||||||||||||
Net sales | $ | 376,562 | $ | 763,173 | |||||||||||||
Cost of sales | 5,752,700 | 7,981,413 | |||||||||||||||
Warranty expense | 92,191 | 7,972,152 | |||||||||||||||
Gross loss | (5,468,329) | (15,190,392) | |||||||||||||||
Operating expenses | |||||||||||||||||
Selling, general and administrative | 10,199,534 | 11,485,482 | |||||||||||||||
Research and development | 8,199,074 | 7,391,693 | |||||||||||||||
Total operating expenses | 18,398,608 | 18,877,175 | |||||||||||||||
Other income | 15,849,800 | — | |||||||||||||||
Loss from operations | (8,017,137) | (34,067,567) | |||||||||||||||
Interest expense, net | 29,145,690 | 2,434,749 | |||||||||||||||
Loss before provision for income taxes | (37,162,827) | (36,502,316) | |||||||||||||||
Provision for income taxes | — | — | |||||||||||||||
Net loss | $ | (37,162,827) | $ | (36,502,316) | |||||||||||||
Net loss attributable to common stockholders per share - basic and diluted | $ | (0.58) | $ | (0.74) | |||||||||||||
Weighted average number of common shares outstanding | 64,314,756 | 50,377,909 |
Common Stock |
Series A
Preferred Stock |
Additional
Paid-in Capital |
Accumulated
Deficit |
Total
Stockholders’ Equity (Deficit) |
|||||||||||||||||||||||||||||||||||||||||||||||||
Number
of Shares |
Amount |
Number
of Shares |
Amount | ||||||||||||||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2017 | 41,529,181 | $ | 41,529 | — | $ | — | $ | 107,760,036 | $ | (104,290,001) | $ | 3,511,564 | |||||||||||||||||||||||||||||||||||||||||
Issuance of common stock
|
14,614,500 | 14,614 | — | — | 16,105,698 | — | 16,120,312 | ||||||||||||||||||||||||||||||||||||||||||||||
Stock options and warrants exercised
|
44,643 | 45 | — | — | 90,020 | — | 90,065 | ||||||||||||||||||||||||||||||||||||||||||||||
Exchange offer - 2017 Warrants deemed dividend | — | — | — | — | 765,179 | (765,179) | — | ||||||||||||||||||||||||||||||||||||||||||||||
Exchange offer - 2017 Warrants | 1,968,736 | 1,969 | — | — | (1,969) | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
Conversion of accounts payable
|
113,874 | 114 | — | — | 298,236 | — | 298,350 | ||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 1,059,582 | — | 1,059,582 | ||||||||||||||||||||||||||||||||||||||||||||||
Net loss for the year ended December 31, 2018 | — | — | — | — | — | (36,502,316) | (36,502,316) | ||||||||||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2018 | 58,270,934 | 58,271 | — | — | 126,076,782 | (141,557,496) | (15,422,443) | ||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock
|
7,183,488 | 7,184 | — | — | 5,921,051 | — | 5,928,235 | ||||||||||||||||||||||||||||||||||||||||||||||
Stock options and warrants exercised, and vesting of restricted shares
|
630,141 | 630 | — | — | 34,676 | — | 35,306 | ||||||||||||||||||||||||||||||||||||||||||||||
Reclassification of warrants to equity | — | — | — | — | 857,072 | — | 857,072 | ||||||||||||||||||||||||||||||||||||||||||||||
Deemed dividend | 116,496 | 116 | — | — | 86,091 | (86,207) | — | ||||||||||||||||||||||||||||||||||||||||||||||
Value of warrants issued with Series B Preferred Stock | — | — | — | — | 6,709,961 | — | 6,709,961 | ||||||||||||||||||||||||||||||||||||||||||||||
Value of warrants issued with Convertible Note | — | — | — | — | 430,000 | — | 430,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Common stock issued for preferred stock dividends | 718,755 | 719 | — | — | 1,166,052 | — | 1,166,771 | ||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Convertible Note
|
185,186 | 185 | — | — | 564,632 | — | 564,817 | ||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 1,979,998 | — | 1,979,998 | ||||||||||||||||||||||||||||||||||||||||||||||
Net loss for the year ended December 31, 2019 | — | — | — | — | — | (37,162,827) | (37,162,827) | ||||||||||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2019 | 67,105,000 | $ | 67,105 | — | $ | — | $ | 143,826,315 | $ | (178,806,530) | $ | (34,913,110) |
For the Years Ended December 31, | |||||||||||||||||
2019 | 2018 | ||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||
Net loss | $ | (37,162,827) | $ | (36,502,316) | |||||||||||||
Adjustments to reconcile net loss to net cash used in operations: | |||||||||||||||||
Depreciation | 388,401 | 348,339 | |||||||||||||||
Amortization of discount and debt issuance costs on long-term debt | 3,518,356 | 4,598,089 | |||||||||||||||
Amortization of discount on mandatory redeemable Series B preferred stock | 852,869 | — | |||||||||||||||
Change in fair value of Convertible Note and loss on conversion to common stock | 1,064,817 | — | |||||||||||||||
Change in fair value of warrant liability | 15,369,253 | (2,683,470) | |||||||||||||||
Dividends for mandatory redeemable Series B preferred stock paid in common stock | 1,166,771 | — | |||||||||||||||
Stock-based compensation | 1,979,998 | 1,059,582 | |||||||||||||||
Write down of inventory | 694,448 | 2,488,100 | |||||||||||||||
Gain on divestiture | (3,655,000) | — | |||||||||||||||
Investment received from license of intellectual property | (12,194,800) | — | |||||||||||||||
Loss on sale of fixed assets | 19,367 | 28,645 | |||||||||||||||
Effects of changes in operating assets and liabilities: | |||||||||||||||||
Accounts and lease receivable | 76,163 | 1,024,366 | |||||||||||||||
Inventory | 41,022 | (399,774) | |||||||||||||||
Prepaid expenses and deposits | (4,367,928) | (1,328,461) | |||||||||||||||
Accounts payable and accrued liabilities | (3,502,682) | 2,399,877 | |||||||||||||||
Warranty liability | (1,056,905) | 6,916,209 | |||||||||||||||
Accounts payable, related parties | — | (54,914) | |||||||||||||||
Customer deposits | (103,000) | 351,595 | |||||||||||||||
Net cash used in operating activities | (36,871,677) | (21,754,133) | |||||||||||||||
Cash flows from investing activities: | |||||||||||||||||
Capital expenditures | (2,005,498) | (23,222) | |||||||||||||||
Net proceeds received on divestiture | 3,655,000 | — | |||||||||||||||
Proceeds from sale of fixed assets | 5,000 | 4,800 | |||||||||||||||
Net cash provided by (used in) investing activities | 1,654,502 | (18,422) | |||||||||||||||
Cash flows from financing activities: | |||||||||||||||||
Proceeds from notes payable | 5,854,140 | — | |||||||||||||||
Payments on notes payable | (5,854,140) | (5,750,000) | |||||||||||||||
Proceeds from issuance of mandatory redeemable Series B preferred stock | 25,000,000 | — | |||||||||||||||
Proceeds from issuance of Convertible Note | 38,950,000 | — | |||||||||||||||
(Repayment) proceeds, Duke financing obligation | (1,340,700) | 1,340,700 | |||||||||||||||
Proceeds from long-term debt | — | 17,800,000 | |||||||||||||||
Payments on long-term debt | (10,000,000) | (9,891,378) | |||||||||||||||
Loan issuance costs | — | (792,221) | |||||||||||||||
Proceeds from issuance of common stock | 5,928,235 | 16,418,662 | |||||||||||||||
Proceeds from exercise of warrants and options | 35,306 | 90,065 | |||||||||||||||
Net cash provided by financing activities | 58,572,841 | 19,215,828 | |||||||||||||||
Change in cash, cash equivalents and restricted cash | 23,355,666 | (2,556,727) | |||||||||||||||
Cash, cash equivalents and restricted cash, beginning of the year | 1,512,750 | 4,069,477 | |||||||||||||||
Cash, cash equivalents and restricted cash, end of the year | $ | 24,868,416 | $ | 1,512,750 |
December 31 | |||||||||||||||||
2019 | 2018 | ||||||||||||||||
Cash and cash equivalents | $ | 23,868,416 | $ | 1,512,750 | |||||||||||||
Restricted cash held in escrow | 1,000,000 | — | |||||||||||||||
Total cash, cash equivalents and restricted cash | $ | 24,868,416 | $ | 1,512,750 |
Buildings |
15 - 39 years
|
||||
Software |
3 - 6 years
|
||||
Equipment | 5 years | ||||
Vehicles and prototypes |
3 - 5 years
|
December 31, | |||||||||||||||||
2019 | 2018 | ||||||||||||||||
Balance at beginning of year | $ | 7,058,769 | $ | 142,560 | |||||||||||||
Accrual for warranty | 92,191 | 7,981,413 | |||||||||||||||
Warranty costs incurred | (1,149,096) | (1,065,204) | |||||||||||||||
Balance at end of year | $ | 6,001,864 | $ | 7,058,769 |
Years Ended December 31, | ||||||||||||||||||||
2019 | 2018 | |||||||||||||||||||
Net loss | $ | (37,162,827) | $ | (36,502,316) | ||||||||||||||||
Deemed dividends | 86,207 | 765,179 | ||||||||||||||||||
Net loss attributable to common stockholders | $ | (37,249,034) | $ | (37,267,495) | ||||||||||||||||
Basic weighted average shares outstanding | 64,314,756 | 50,377,909 | ||||||||||||||||||
Dilutive effect of options and warrants | — | — | ||||||||||||||||||
Dilutive effect of Convertible Note | — | — | ||||||||||||||||||
Diluted weighted average shares outstanding | 64,314,756 | 50,377,909 | ||||||||||||||||||
Anti-dilutive options and warrants excluded from diluted average shares outstanding | 36,021,502 | 21,686,465 |
December 31, | |||||||||||||||||
2019 | 2018 | ||||||||||||||||
Raw materials | $ | 3,741,097 | $ | 4,319,637 | |||||||||||||
Work in process | 422,176 | 702,079 | |||||||||||||||
Finished goods | — | — | |||||||||||||||
4,163,273 | 5,021,716 | ||||||||||||||||
Less: Inventory reserve | (2,365,127) | (2,488,100) | |||||||||||||||
Total Inventory, net | $ | 1,798,146 | $ | 2,533,616 |
Years Ended December 31, | |||||||||||||||||
2019 | 2018 | ||||||||||||||||
Automotive | $ | 240,280 | $ | 498,000 | |||||||||||||
Other | 136,282 | 265,173 | |||||||||||||||
Total revenues | $ | 376,562 | $ | 763,173 |
December 31, | |||||||||||||||||
2019 | 2018 | ||||||||||||||||
Land | $ | 700,000 | $ | 700,000 | |||||||||||||
Buildings | 5,900,000 | 5,900,000 | |||||||||||||||
Leasehold Improvements | — | 19,236 | |||||||||||||||
Software | 28,352 | 102,367 | |||||||||||||||
Equipment | 860,104 | 836,646 | |||||||||||||||
Construction in progress | 1,925,500 | — | |||||||||||||||
Vehicles and prototypes | 65,529 | 86,679 | |||||||||||||||
9,479,485 | 7,644,928 | ||||||||||||||||
Less: accumulated depreciation | (2,649,304) | (2,407,477) | |||||||||||||||
Property, plant and equipment, net | $ | 6,830,181 | $ | 5,237,451 |
December 31, | |||||||||||||||||
2019 | 2018 | ||||||||||||||||
Convertible Note, at fair value | $ | 39,020,000 | $ | — | |||||||||||||
Marathon Tranche I Loan
|
— | 10,000,000 | |||||||||||||||
Marathon Credit Agreement unamortized debt discount and issuance costs
|
— | (1,687,921) | |||||||||||||||
Net Marathon Credit Agreement
|
— | 8,312,079 | |||||||||||||||
Total long-term debt | 39,020,000 | 8,312,079 | |||||||||||||||
Less current portion | 19,620,000 | — | |||||||||||||||
Long-term debt, net of current portion | $ | 19,400,000 | $ | 8,312,079 |
2020 | $ | 19,500,000 | |||
2021 | 18,000,000 | ||||
2022 | 3,000,000 | ||||
$ | 40,500,000 |
Years Ended December 31, | |||||||||||||||||
2019 | 2018 | ||||||||||||||||
Current | |||||||||||||||||
Federal | $ | — | $ | — | |||||||||||||
State and Local | — | — | |||||||||||||||
Total Current | — | — | |||||||||||||||
Deferred | |||||||||||||||||
Federal | — | — | |||||||||||||||
State and Local | — | — | |||||||||||||||
Total Deferred | — | — | |||||||||||||||
Total provision for income taxes | $ | — | $ | — |
Years Ended December 31, | |||||||||||||||||
2019 | 2018 | ||||||||||||||||
Federal tax benefit at statutory rates | 21.0 | % | 21.0 | % | |||||||||||||
State and local taxes | (0.6) | % | 0.8 | % | |||||||||||||
Mark-to-market adjustment on stock warrants | (9.3) | % | 1.5 | % | |||||||||||||
Other permanent differences and credits | (0.8) | % | 0.0 | % | |||||||||||||
Change in valuation allowance | (10.3) | % | (23.3) | % | |||||||||||||
Total tax benefit | 0.0 | % | 0.0 | % |
December 31 | |||||||||||||||||
2019 | 2018 | ||||||||||||||||
Deferred Tax Assets: | |||||||||||||||||
Accrued expenses and reserves | $ | 802,526 | $ | 850,857 | |||||||||||||
Warranty reserve | 1,275,047 | 1,539,765 | |||||||||||||||
Non-qualified stock options | 961,919 | 1,034,261 | |||||||||||||||
Property, plant and equipment | 202,755 | 183,917 | |||||||||||||||
Disallowed interest expense | — | 1,118,212 | |||||||||||||||
Other temporary differences | (88,200) | — | |||||||||||||||
Net operating losses | 30,213,192 | 24,818,785 | |||||||||||||||
Total Deferred Tax Assets | 33,367,239 | 29,545,797 | |||||||||||||||
Valuation Allowance | (33,367,239) | (29,545,797) | |||||||||||||||
Total Deferred Tax Assets, net of valuation allowance | $ | — | $ | — |
2019 | 2018 | ||||||||||
Unrecognized tax benefits - January 1 | $ | 1,163,282 | $ | 1,163,282 | |||||||
Gross increases - tax positions in prior period | — | — | |||||||||
Gross decreases - tax positions in prior period | — | — | |||||||||
Gross increases - tax positions in current period | — | — | |||||||||
Settlement | — | — | |||||||||
Lapse of statute of limitations | — | — | |||||||||
Unrecognized tax benefits - December 31 | $ | 1,163,282 | $ | 1,163,282 |
December 31, | ||||||||||||||||||||
2019 | 2018 | |||||||||||||||||||
Warrant liability, beginning of year | $ | 1,822,819 | $ | — | ||||||||||||||||
Fair value for new warrants issued | — | 4,506,289 | ||||||||||||||||||
Change in fair value for the year | 15,369,253 | (2,683,470) | ||||||||||||||||||
Reclassification to additional paid-in capital | (857,072) | — | ||||||||||||||||||
Warrant liability, end of year | $ | 16,335,000 | $ | 1,822,819 |
December 31, | ||||||||||||||||||||
2019 | 2018 | |||||||||||||||||||
Convertible Note, beginning of year | $ | — | $ | — | ||||||||||||||||
Fair value of Convertible Note on issuance | 38,520,000 | — | ||||||||||||||||||
Conversion of Convertible Note into common stock | (481,728) | — | ||||||||||||||||||
Change in fair value for the year | 981,728 | — | ||||||||||||||||||
Convertible Note, end of year | $ | 39,020,000 | $ | — |
Years Ended December 31, | |||||||||||||||||
2019 | 2018 | ||||||||||||||||
Stock options | $ | 1,542,644 | $ | 1,059,582 | |||||||||||||
Restricted stock | 437,354 | — | |||||||||||||||
Total stock-based compensation expense | $ | 1,979,998 | $ | 1,059,582 |
Number of Options |
Weighted
Average Exercise Price per Option |
Weighted
Average Grant Date Fair Value per Option |
Weighted
Average Remaining Contractual Life (Years) |
|||||||||||||||||||||||
Balance December 31, 2017 | 3,851,371 | $ | 3.11 | |||||||||||||||||||||||
Granted | 340,000 | 1.18 | 0.54 | |||||||||||||||||||||||
Exercised | (52,500) | 1.24 | ||||||||||||||||||||||||
Forfeited | — | — | ||||||||||||||||||||||||
Expired | (271,250) | 3.22 | ||||||||||||||||||||||||
Balance December 31, 2018 | 3,867,621 | 4.05 | ||||||||||||||||||||||||
Granted | 2,450,000 | 0.96 | 0.51 | |||||||||||||||||||||||
Exercised | (736,552) | 0.72 | ||||||||||||||||||||||||
Forfeited | (907,500) | 4.49 | ||||||||||||||||||||||||
Expired | (948,569) | 5.01 | ||||||||||||||||||||||||
Balance December 31, 2019 | 3,725,000 | $ | 2.32 | |||||||||||||||||||||||
Number of options exercisable at December 31, 2019 | 3,069,000 | $ | 2.35 | 5.4 |
Number of Unvested Shares | Weighted Average Grant Date Fair Value per Share | |||||||||||||
Balance December 31, 2018 | — | $ | — | |||||||||||
Granted | 1,805,222 | 2.57 | ||||||||||||
Vested | (36,496) | 2.74 | ||||||||||||
Forfeited | — | — | ||||||||||||
Balance December 31, 2019 | 1,768,726 | $ | 2.57 |
Number of Warrants | Weighted Average Exercise Price per Warrant | |||||||||||||
Balance December 31, 2017 | 2,618,307 | $ | 5.28 | |||||||||||
Granted, Arosa Loan Agreement | 7,147,147 | |||||||||||||
Granted, Marathon Credit Agreement | 8,053,390 | |||||||||||||
Exercised | — | |||||||||||||
Balance December 31, 2018 | 17,818,844 | 1.84 | ||||||||||||
Granted, Series B Preferred Stock | 9,262,500 | |||||||||||||
Granted, Marathon Credit Agreement | 3,379,466 | |||||||||||||
Granted, Other | 66,966 | |||||||||||||
Exercised | — | |||||||||||||
Balance December 31, 2019 | 30,527,776 | $ | 1.82 |
For the Years Ended December 31, | |||||||||||||||||
2019
|
2018 | ||||||||||||||||
Technology licensing income | $ | 12,194,800 | $ | — | |||||||||||||
Gain on divestiture | 3,655,000 | — | |||||||||||||||
Total other income | $ | 15,849,800 | $ | — |
Name | Age | Position | ||||||||||||
Raymond J. Chess | 62 | Director, Chairman | ||||||||||||
Harry DeMott | 53 | Director | ||||||||||||
H. Benjamin Samuels | 52 | Director | ||||||||||||
Gerald B. Budde | 58 | Director | ||||||||||||
Michael L. Clark | 48 | Director | ||||||||||||
Duane A. Hughes | 56 | President and Chief Executive Officer | ||||||||||||
Robert Willison | 58 | Chief Operating Officer | ||||||||||||
Steve Schrader | 57 | Chief Financial Officer | ||||||||||||
Stephen Fleming | 47 | General Counsel and Vice President | ||||||||||||
Anthony Furey | 47 | Vice President of Finance | ||||||||||||
Gregory Ackerson | 43 | Controller |
Nominating and Corporate Governance Committee | Compensation Committee | Audit Committee | ||||||||||||
Raymond J. Chess (Chairman) | Harry DeMott (Chairman) | Gerald B. Budde (Chairman) | ||||||||||||
Gerald B. Budde | Gerald B. Budde | Raymond J. Chess | ||||||||||||
Harry DeMott | H. Benjamin Samuels | H. Benjamin Samuels | ||||||||||||
Michael L. Clark | Michael L. Clark |
Name | Age | Position | ||||||||||||
Duane A. Hughes | 56 | President and Chief Executive Officer | ||||||||||||
Robert Willison | 58 | Chief Operating Officer | ||||||||||||
Stephen Fleming | 47 | General Counsel and Vice President |
Executive | 2018 Position |
2018
Base Salary |
2019 Position |
2019
Base Salary |
% Change | |||||||||||||||||||||||||||
Duane A. Hughes | Chief Operating Officer | $275,000 | President and Chief Executive Officer | $475,000 | 73% | |||||||||||||||||||||||||||
Robert Willison | n/a | n/a | Chief Operating Officer | $300,000 | n/a | |||||||||||||||||||||||||||
Stephen Fleming | n/a | n/a | General Counsel and Vice President | $300,000 | n/a |
Bonus Target as Percent of Base | Maximum Bonus as Percent of Base | |||||||
President & CEO | 100% | 200% | ||||||
COO | 75% | 100% | ||||||
General Counsel and VP | 50% | 75% |
Name and Principal Position | Year |
Salary
($) |
Bonus
($) |
Stock Awards
($)(1) |
Option Awards
($)(2) |
Non-equity Incentive
Plan Compensation |
Change in Pension Value
and Non Qualified Preferred Compensation Earnings ($) |
All Other Compensation
($) |
Total
($) |
|||||||||||||||||||||||||||||||||||||||||||||||
Duane A. Hughes (3) | 2019 | $ | 391,058 | $ | 50,000 | $ | 600,000 | $ | 666,015 | $ | 132,500 | $ | 1,839,573 | |||||||||||||||||||||||||||||||||||||||||||
President and Chief Executive Officer
|
2018 | 275,000 | 275,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
2017 | 253,750 | 796,400 | 1,050,150 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Robert Willison (4) | 2019 | 217,308 | 300,000 | 170,600 | 42,000 | 729,908 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Chief Operating Officer | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stephen Fleming (5) | 2019 | 32,307 | 1,300,000 | 45,000 | 295,000 | 1,672,307 | ||||||||||||||||||||||||||||||||||||||||||||||||||
General Counsel and Vice President | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Name | Grant date | Threshold | Target | Maximum |
All Other Stock Awards:
Number of Shares of Stock or Units # |
All Other Stock Awards:
Number of Securities Underlying (#) |
Exercise Price of
Options Awards ($/sh) |
Grant Data Fair Value of
Stock and Options Awards $ (1) |
||||||||||||||||||||||||||||||||||||||||||
Duane A. Hughes | 02/4/2019 | 1,000,000 | $ | 634,300 | ||||||||||||||||||||||||||||||||||||||||||||||
President and Chief Executive Officer
|
02/4/2019 | 50,000 | 31,715 | |||||||||||||||||||||||||||||||||||||||||||||||
11/6/2019 | 239,044 | 600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
Rob Willison | 5/2/2019 | 400,000 | 170,600 | |||||||||||||||||||||||||||||||||||||||||||||||
Chief Operating Officer | 11/06/2019 | 119,522 | 300,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Stephen Fleming | 11/6/2019 | 517,928 | 1,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||
General Counsel and Vice President |
Outstanding Equity Awards at Year-End | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Option Awards | Stock Awards | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Name and Principal Position |
Number of Securities
underlying unexercised options (#) Exercisable |
Number of securities
underlying unexercised options (#) Unexercisable |
Equity incentive
plan awards: number of securities underlying unexercised options (3) |
Options exercise
price ($) |
Option expiration date |
Number of shares
or units of stock that have not vested (#) |
Market value of
shares or units of stock that have not vested ($) |
Equity incentive
plan awards: Number if unearned shares other rights that have not vested (#) |
Equity incentive
awards: Market or payout value of unearned shares, units or other rights that have not vested ($) (1) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Duane A. Hughes | — | — | — | — | — | 239,044 | $ | 726,694 | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
President and Chief Executive Officer | 1,000,000 | 0.97 | 2/4/2029 | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18,000 | 32,000 | 0.97 | 2/4/2029 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
275,000 | 125,000 | — | 5.28 | 5/19/2027 | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22,000 | — | — | 7.21 | 8/15/2021 | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25,000 | — | — | 4.99 | 2/1/2021 | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20,000 | — | — | 1.75 | 8/11/2020 | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Robert Willison | — | — | — | — | — | 119,522 | 363,347 | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chief Operating Officer | 75,000 | 325,000 | — | 0.93 | 5/2/2024 | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stephen Fleming | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
General Counsel and Vice President | — | — | — | — | — | 517,928 | 1,574,501 | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
46,875 | 103,125 | — | 1.19 | 8/14/2023 |
Name |
Fees Earned or Paid in
Cash $ (1) |
Stock
Awards $ (2) |
Total $ | ||||||||||||||||||||
Raymond J. Chess | $ | 43,330 | $ | 75,000 | $ | 118,330 | |||||||||||||||||
H. Benjamin Samuels | 41,664 | 60,000 | 101,664 | ||||||||||||||||||||
Gerald B. Budde | 41,664 | 60,000 | 101,664 | ||||||||||||||||||||
Harry DeMott | 41,664 | 60,000 | 101,664 | ||||||||||||||||||||
Michael L. Clark | 41,664 | 60,000 | 101,664 |
Name of Beneficial Owner (1) |
Common Stock Beneficially
Owned |
Percentage of
Common stock (2) |
||||||||||||
Marathon Asset Management, L.P. | (3) | 11,467,149 | 14.0 | % | ||||||||||
Joseph T. Lukens | (4) | 7,511,786 | 10.5 | % | ||||||||||
Arosa Opportunistic Fund, L.P. | (5) | 7,927,755 | 9.9 | % | ||||||||||
Seaport Global Capital L.P. | (6) | 6,370,775 | 8.3 | % | ||||||||||
Stephen D. Baksa | (7) | 3,833,174 | 5.4 | % | ||||||||||
Benjamin Samuels † | (8) | 2,133,441 | 3.0 | % | ||||||||||
Duane Hughes † | (9) | 1,624,044 | 2.3 | % | ||||||||||
Stephen Fleming † | (10) | 651,818 | * | |||||||||||
Gerald Budde † | (11) | 247,405 | * | |||||||||||
Robert Willison † | (12) | 219,522 | * | |||||||||||
Raymond Chess † | (13) | 179,289 | * | |||||||||||
Harry DeMott † | (14) | 109,713 | * | |||||||||||
Michael Clark † | (15) | 89,713 | * | |||||||||||
All officers and directors as a group (11 people) | 5,878,324 | 8.1 | % |
2019 | 2018 | |||||||||||||
Audit fees | $ | 285,170 | $ | 233,965 | ||||||||||
Audit-related fees | 22,357 | 20,300 | ||||||||||||
Tax fees | — | — | ||||||||||||
All other fees | — | — | ||||||||||||
Total fees | $ | 307,527 | $ | 254,265 |
Exhibit No. | Description | Form Incorporated From | Report Date | |||||||||||||||||
3.1 | 8-K | 1/4/2010 | ||||||||||||||||||
3.2 | 8-K | 5/25/2010 | ||||||||||||||||||
3.3 | 8-K | 5/25/2010 | ||||||||||||||||||
3.4 | 8-K | 5/25/2010 | ||||||||||||||||||
3.5 | 8-K | 5/25/2010 | ||||||||||||||||||
3.6 | 8-K | 9/10/2010 | ||||||||||||||||||
3.7 | SB-2 | 2/4/2008 | ||||||||||||||||||
3.8 | 8-K | 4/16/2015 | ||||||||||||||||||
3.9 | 8-K | 12/10/2015 | ||||||||||||||||||
3.10 | 10-Q | 8/9/2017 | ||||||||||||||||||
3.11 | 10-Q | 5/7/2019 | ||||||||||||||||||
3.12 | 8-K | 6/6/2019 | ||||||||||||||||||
4.1 | 8-K | 12/21/2015 | ||||||||||||||||||
4.2 | 8-K | 12/21/2015 | ||||||||||||||||||
4.3 | 8-K | 9/9/2016 | ||||||||||||||||||
4.4 | 8-K | 9/14/2017 | ||||||||||||||||||
4.5 | 10-Q | 8/6/2018 | ||||||||||||||||||
4.6 | 8-K | 10/1/2018 | ||||||||||||||||||
4.7 | 8-K | 12/3/2018 | ||||||||||||||||||
4.8 | 8-K | 1/2/2019 | ||||||||||||||||||
4.9 | 8-K | 2/11/2019 | ||||||||||||||||||
4.10 | 8-K | 4/16/2019 | ||||||||||||||||||
4.11 | 8-K | 4/16/2019 | ||||||||||||||||||
4.12 | † | |||||||||||||||||||
10.1 | 8-K | 3/4/2013 | ||||||||||||||||||
10.2 | 8-K | 3/13/2013 | ||||||||||||||||||
10.3 | 8-K | 10/30/2013 | ||||||||||||||||||
10.4 | 8-K | 12/21/2015 | ||||||||||||||||||
10.5 | 8-K | 12/21/2015 | ||||||||||||||||||
10.6 | 8-K | 9/9/2016 | ||||||||||||||||||
10.7 | 8-K | 5/3/2017 |
10.8 | 8-K | 5/19/2017 | ||||||||||||||||||
10.9 | 8-K | 8/11/2017 | ||||||||||||||||||
10.10 | 8-K | 5/19/2017 | ||||||||||||||||||
10.11 | 8-K | 5/19/2017 | ||||||||||||||||||
10.12 | 8-K | 7/10/2018 | ||||||||||||||||||
10.13 | 8-K | 7/10/2018 | ||||||||||||||||||
10.14 | 8-K | 7/10/2018 | ||||||||||||||||||
10.15 | 10-Q | 8/6/2018 | ||||||||||||||||||
10.16 | 8-K | 10/1/2018 | ||||||||||||||||||
10.17 | 8-K | 12/3/2018 | ||||||||||||||||||
10.18 | 8-K | 12/3/2018 | ||||||||||||||||||
10.19 | 8-K | 1/2/2019 | ||||||||||||||||||
10.20 | 8-K | 1/2/2019 | ||||||||||||||||||
10.21 | 8-K | 1/2/2019 | ||||||||||||||||||
10.22 | 8-K | 1/2/2019 | ||||||||||||||||||
10.23 | 8-K | 1/2/2019 | ||||||||||||||||||
10.24 | 8-K | 2/5/2019 | ||||||||||||||||||
10.25 | 8-K | 2/5/2019 | ||||||||||||||||||
10.26 | 8-K | 2/5/2019 | ||||||||||||||||||
10.27 | 10-K | 3/18/2019 |
10.28 | 8-K | 4/30/2019 | ||||||||||||||||||
10.29 | 8-K | 4/30/2019 | ||||||||||||||||||
10.30 | 8-K | 5/31/2019 | ||||||||||||||||||
10.31 | 8-K | 10/1/2019 | ||||||||||||||||||
10.32 | 8-K | 10/1/2019 | ||||||||||||||||||
10.33 | 8-K | 10/1/2019 | ||||||||||||||||||
10.34 | 8-K | 11/6/2019 | ||||||||||||||||||
10.35 | 8-K | 11/6/2019 | ||||||||||||||||||
10.36 | 8-K | 11/6/2019 | ||||||||||||||||||
10.37 | 8-K | 11/6/2019 | ||||||||||||||||||
10.38 | 8-K | 11/6/2019 | ||||||||||||||||||
10.39 | 8-K | 11/6/2019 | ||||||||||||||||||
10.4 | 8-K | 11/27/2019 | ||||||||||||||||||
10.41 | † | |||||||||||||||||||
10.42 | † | |||||||||||||||||||
10.43 | 8-K | 12/9/2019 | ||||||||||||||||||
10.44 | 8-K | 12/9/2019 | ||||||||||||||||||
10.45 | 8-K | 12/9/2019 | ||||||||||||||||||
10.46 | 8-K | 12/9/2019 | ||||||||||||||||||
10.47 | † | |||||||||||||||||||
21.1 | † | |||||||||||||||||||
23.1 | † | |||||||||||||||||||
31.1 | † | |||||||||||||||||||
31.2 | † | |||||||||||||||||||
32.1 | † | |||||||||||||||||||
32.2 | † | |||||||||||||||||||
99.1 | 10-Q | 8/9/2017 | ||||||||||||||||||
99.2 | 10-Q | 8/9/2017 | ||||||||||||||||||
99.3 | 10-Q | 8/9/2017 | ||||||||||||||||||
101.INS | Inline XBRL INSTANCE DOCUMENT |
101.SCH | Inline XBRL Taxonomy Extension Schema Document | |||||||||||||||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||||||||||||||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||||||||||||||||||
101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document | |||||||||||||||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||||||||||||||||
104 | Inline XBRL Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
WORKHORSE GROUP INC. | ||||||||||||||
Dated: | March 13, 2020 | By: | /s/ Duane A. Hughes | |||||||||||
Name: | Duane A. Hughes | |||||||||||||
Title: |
Chief Executive Officer
(Principal Executive Officer) |
|||||||||||||
Dated: | March 13, 2020 | By: | /s/ Steve Schrader | |||||||||||
Name: | Steve Schrader | |||||||||||||
Title: |
Chief Financial Officer
(Principal Financial Officer) |
|||||||||||||
Dated: | March 13, 2020 | By: | /s/ Gregory T. Ackerson | |||||||||||
Name: | Gregory T. Ackerson | |||||||||||||
Title: |
Controller
(Principal Accounting Officer) |
Signature | Title | |||||||
/s/ Duane A. Hughes |
Chief Executive Officer and Director
(Principal Executive Officer) |
|||||||
Duane A. Hughes | ||||||||
/s/ Steve Schrader |
Chief Financial Officer
(Principal Financial Officer) |
|||||||
Steve Schrader | ||||||||
/s/ Raymond Chess | Director | |||||||
Raymond Chess | ||||||||
/s/ Gerald B. Budde | Director | |||||||
Gerald Budde | ||||||||
/s/ H. Benjamin Samuels | Director | |||||||
H. Benjamin Samuels | ||||||||
/s/ Harry DeMott | Director | |||||||
Harry DeMott | ||||||||
/s/ Michael L. Clark | Director | |||||||
Michael L. Clark |
Term
|
Section
|
||||
Acquired Assets
|
2.1 | ||||
Adjustment Date
|
3.3 | ||||
Agreed Allocation
|
3.7 | ||||
Agreement
|
Preamble
|
||||
Agreement Matters
|
4.9 | ||||
Assumed Liabilities
|
2.3 | ||||
Buyer
|
Preamble
|
||||
Closing
|
3.1 | ||||
Closing Date
|
3.1 | ||||
Escrow Agent
|
3.3 | ||||
Escrow Shares
|
3.3 | ||||
Prime Contract
|
Recitals
|
||||
Proposed Allocation
|
3.7 | ||||
Purchase Price
|
3.2 | ||||
Retained Assets
|
2.2 | ||||
Retained Liabilities
|
2.4 | ||||
Seller
|
Preamble
|
||||
USPS
|
Recitals
|
1. | Definitions. |
(a) |
“ Board ” - The Board of Directors of the Company.
|
(b) |
“ Cause ” means (a) embezzlement or misappropriation of funds; (b) conviction of, or entry of a plea of nolo contendre to, a felony involving moral turpitude; (c) commission of material acts of dishonesty, fraud, or deceit; (d) breach of any material provisions of any employment agreement, confidentiality agreement or invention assignment agreement; (e) habitual or willful neglect of duties; (f) breach of fiduciary duty; or (g) material violation of any other duty whether imposed by law or the Board.
|
(c) |
“ Code ” - The Internal Revenue Code of 1986, as amended from time to time.
|
(d) |
“ Committee ” - The Compensation Committee of the Company’s Board, or such other committee of the Board that is designated by the Board to administer the Plan, composed of not less than two members of the Board who are disinterested persons, as contemplated by Rule 16b-3 (“ Rule 16b-3 ”) promulgated under the Exchange Act.
|
(e) |
“ Company ” - WORKHORSE GROUP INC. and its subsidiaries including subsidiaries of subsidiaries.
|
(f) |
“ Exchange Act ” - The Securities Exchange Act of 1934, as amended from time to time.
|
(g) |
“ Fair Market Value ” - The fair market value of the Company’s issued and outstanding Stock as determined in good faith by the Board or Committee.
|
(h) |
“ Grant ” - The grant of any form of stock option, stock award, or stock purchase offer, whether granted singly, in combination or in tandem, to a Participant pursuant to such terms, conditions and limitations as the Committee may establish in order to fulfill the objectives of the Plan.
|
(i) |
“ Grant Agreement ” - An agreement between the Company and a Participant that sets forth the terms, conditions and limitations applicable to a Grant.
|
(j) |
“ Option ” - Either an Incentive Stock Option, in accordance with Section 422 of Code, or a Nonstatutory Option, to purchase the Company’s Stock that may be awarded to a Participant under the Plan. A Participant who receives an award of an Option shall be referred to as an “ Optionee .”
|
(k) |
“ Participant ” - A director, officer, employee or consultant of the Company to whom an Award has been made under the Plan.
|
(l) |
“ Restricted Stock Purchase Offer ” - A Grant of the right to purchase a specified number of shares of Stock pursuant to a written agreement issued under the Plan.
|
(m) |
“ Securities Act ” - The Securities Act of 1933, as amended from time to time.
|
(n) |
“ Stock ” - Authorized and issued or unissued shares of common stock of the Company.
|
(o) |
“ Stock Award ” - A Grant made under the Plan in stock, denominated in units of stock or denominated in some other method reflecting an increase in value of stock or some other security of the Company, for which the Participant is not obligated to pay additional consideration.
|
2. | Administration. The Plan shall be administered by the Board, provided however, that the Board may delegate such administration to the Committee. Subject to the provisions of the Plan, the Board and/or the Committee shall have authority to (a) grant, in its discretion, Incentive Stock Options in accordance with Section 422 of the Code, or Nonstatutory Options, Stock Awards or Restricted Stock Purchase Offers; (b) determine in good faith the fair market value of the Stock covered by any Grant; (c) determine which eligible persons shall receive Grants and the number of shares, restrictions, terms and conditions (including performance terms and conditions or market criteria) to be included in such Grants; (d) construe and interpret the Plan; (e) promulgate, amend and rescind rules and regulations relating to its administration, and correct defects, omissions and inconsistencies in the Plan or any Grant; (f) consistent with the Plan and with the consent of the Participant, as appropriate, amend any outstanding Grant or amend the exercise date or dates thereof; (g) determine the duration and purpose of leaves of absence which may be granted to Participants without constituting termination of their employment for the purpose of the Plan or any Grant; and (h) make all other determinations necessary or advisable for the Plan’s administration. The interpretation and construction by the Board of any provisions of the Plan or selection of Participants shall be conclusive and final. No member of the Board or the Committee shall be liable for any action or determination made in good faith with respect to the Plan or any Grant made thereunder. |
3. | Eligibility; Cancellation. |
(a) |
General: The persons who shall be eligible to receive Grants shall be directors, officers, employees or consultants to the Company. The term consultant shall mean any person, other than an employee, who is engaged by the Company to render services and is compensated for such services. An Optionee may hold more than one Option. Any issuance of a Grant to an officer or director of the Company subsequent to the first registration of any of the securities of the Company under the Exchange Act shall comply with the requirements of Rule 16b-3.
|
(b) |
Incentive Stock Options: Incentive Stock Options may only be issued to employees of the Company. Incentive Stock Options may be granted to officers or directors, provided they are also employees of the Company. Payment of a director’s fee shall not be sufficient to constitute employment by the Company.
|
The Company shall not grant an Incentive Stock Option under the Plan to any employee if such Grant would result in such employee holding the right to exercise for the first time in any one calendar year, under all Incentive Stock Options granted under the Plan or any other plan maintained by the Company, with respect to shares of Stock having an aggregate fair market value, determined as of the date of the Option is granted, in excess of $100,000. Should it be determined that an Incentive Stock Option granted under the Plan exceeds such maximum for any reason other than a failure in good faith to value the Stock subject to such option, the excess portion of such option shall be considered a Nonstatutory Option. To the extent the employee holds two (2) or more such Options which become exercisable for the first time in the same calendar year, the foregoing limitation on the exercisability of such Option as Incentive Stock Options under the Federal tax laws shall be applied on the basis of the order in which such Options are granted. If, for any reason, an entire Option does not qualify as an Incentive Stock Option by reason of exceeding such maximum, such Option shall be considered a Nonstatutory Option. |
(c) |
Nonstatutory Option: The provisions of the foregoing Section 3(b) shall not apply to any Option designated as a “ Nonstatutory Option ” or which sets forth the intention of the parties that the Option be a Nonstatutory Option.
|
(d) |
Stock Awards and Restricted Stock Purchase Offers: The provisions of the foregoing Section 3(b) shall not apply to any Stock Award or Restricted Stock Purchase Offer under the Plan.
|
(e) |
Cancellation and Rescission of Grants. Unless an agreement with a directors, officers, employees or consultants specifies otherwise, the Board or Committee, as applicable, may cancel any unexpired, unpaid, or deferred Grants at any time if the Optionee or Participant is not in compliance with all other applicable provisions of its agreement pertaining to the Grant and/or the Plan.
|
Upon exercise, payment or delivery pursuant to a Grant, the Optionee or Participant shall certify on a form acceptable to the Board that he or she is in compliance with the terms and conditions of the Plan. Failure to comply with all of the provisions of this Section 3(e) prior to, or during the six months after, any exercise, payment or delivery pursuant to a Grant shall cause such exercise, payment or delivery to be rescinded. The Company shall notify the Optionee or Participant in writing of any such rescission within two years after such exercise, payment or delivery. Within ten days after receiving such a notice from the Company, the Optionee or Participant shall pay to the Company the amount of any gain realized or payment received as a result of the rescinded exercise, payment or delivery pursuant to a Grant. Such payment shall be made either in cash or by returning to the Company the number of shares of Stock that the Optionee or Participant received in connection with the rescinded exercise, payment or delivery. |
4. | Stock. |
(a) |
Authorized Stock: Stock subject to Grants may be either unissued or reacquired Stock.
|
(b) |
Number of Shares: Subject to adjustment as provided in Section 5(i) of the Plan, the total number of shares of Stock which may be purchased or granted directly by Options, Stock Awards or Restricted Stock Purchase Offers, or purchased indirectly through exercise of Options granted under the Plan shall not exceed 8,000,000. If any Grant shall for any reason terminate or expire, any shares allocated thereto but remaining unpurchased upon such expiration or termination shall again be available for Grants with respect thereto under the Plan as though no Grant had previously occurred with respect to such shares. Any shares of Stock issued pursuant to a Grant and repurchased pursuant to the terms thereof shall be available for future Grants as though not previously covered by a Grant.
|
(c) |
Reservation of Shares: The Company shall reserve and keep available at all times during the term of the Plan such number of shares as shall be sufficient to satisfy the requirements of the Plan. If, after reasonable efforts, which efforts shall not include the registration of the Plan or Grants under the Securities Act, the Company is unable to obtain authority from any applicable regulatory body, which authorization is deemed necessary by legal counsel for the Company for the lawful issuance of shares hereunder, the Company shall be relieved of any liability with respect to its failure to issue and sell the shares for which such requisite authority was so deemed necessary unless and until such authority is obtained.
|
(d) |
Application of Funds : The proceeds received by the Company from the sale of Stock pursuant to the exercise of Options or rights under Stock Purchase Agreements will be used for general corporate purposes.
|
(e) |
No Obligation to Exercise : The issuance of a Grant shall impose no obligation upon the Participant to exercise any rights under such Grant.
|
5. | Terms and Conditions of Options. Options granted hereunder shall be evidenced by agreements between the Company and the respective Optionees, in such form and substance as the Board or Committee shall from time to time approve. Option agreements need not be identical, and in each case may include such provisions as the Board or Committee may determine, but all such agreements shall be subject to and limited by the following terms and conditions: |
(a) |
Number of Shares: Each Option shall state the number of shares to which it pertains.
|
(b) |
Exercise Price: Each Option shall state the exercise price, which shall be determined as follows:
|
(i) |
Any Incentive Stock Option granted to a person who at the time the Option is granted owns (or is deemed to own pursuant to Section 424(d) of the Code) stock possessing more than ten percent (10%) of the total combined voting power or value of all classes of stock of the Company (“ Ten Percent Holder ”) shall have an exercise price of no less than 110% of the Fair Market Value of the Stock as of the date of grant; and
|
(ii) | Incentive Stock Options granted to a person who at the time the Option is granted is not a Ten Percent Holder and Nonstatutory Options shall have an exercise price of no less than 100% of the Fair Market Value of the Stock as of the date of grant. |
For the purposes of this Section 5(b), Fair Market Value , unless otherwise required by any applicable provision of the Code or any regulations issued thereunder, means, as of any given date: (i) if the common stock is listed on a national securities exchange, the closing price of the common stock in the principal trading market for the common stock on such date, as reported by the exchange (or on the last preceding trading date if such security was not traded on such date); (ii) if the common stock is not listed on a national securities exchange, but is traded in the over-the-counter market, the average of the bid and asked prices on such date, as reported by the OTC Bulletin Board or the OTC Markets Inc. or similar publisher of such quotations; and (iii) if the fair market value of the common stock cannot be determined pursuant to clause (i) or (ii) above or if there is no or limited trading volume or limited liquidity in the common stock as determined by the Board in its sole discretion, the Fair Market Value shall be determined by the Board, which determination shall be conclusive and binding.
|
(c) |
Medium and Time of Payment: The exercise price shall become immediately due upon exercise of the Option and shall be paid in cash or check made payable to the Company. Should the Company’s outstanding Stock be registered under Section 12(g) of the Exchange Act at the time the Option is exercised, then the exercise price may also be paid as follows:
|
(i) | in shares of Stock held by the Optionee for the requisite period necessary to avoid a charge to the Company’s earnings for financial reporting purposes and valued at Fair Market Value on the exercise date, or |
(ii) | through a special sale and remittance procedure pursuant to which the Optionee shall concurrently provide irrevocable written instructions (a) to a Company designated brokerage firm to effect the immediate sale of the purchased shares and remit to the Company, out of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate exercise price payable for the purchased shares plus all applicable Federal, state and local income and employment taxes required to be withheld by the Company by reason of such purchase and (b) to the Company to deliver the purchased shares directly to such brokerage firm in order to complete the sale transaction. |
At the discretion of the Board, exercisable either at the time of Option grant or of Option exercise, the exercise price may also be paid (i) by Optionee’s delivery of a promissory note in form and substance satisfactory to the Company and permissible under applicable securities rules and bearing interest at a rate determined by the Board in its sole discretion, but in no event less than the minimum rate of interest required to avoid the imputation of compensation income to the Optionee under the Federal tax laws, or (ii) in such other form of consideration permitted by the State of Nevada corporations law as may be acceptable to the Board including cashless exercise. |
(d) |
Term and Exercise of Options: Any Option granted to an employee of the Company shall become exercisable over a period of no longer than five (5) years and no less than twenty percent (20%) of the shares covered thereby shall become exercisable annually unless the Board determines otherwise. No Option shall be exercisable, in whole or in part, prior to one (1) year from the date it is granted unless the Board shall specifically determine otherwise, as provided herein. In no event shall any Option be exercisable after the expiration of ten (10) years from the date it is granted, and no Incentive Stock Option granted to a Ten Percent Holder shall, by its terms, be exercisable after the expiration of five (5) years from the date of the Option. Unless otherwise specified by the Board or the Committee in the resolution authorizing such Option, the date of grant of an Option shall be deemed to be the date upon which the Board or the Committee authorizes the granting of such Option.
|
(e) |
Termination of Status as Employee, Consultant or Director: If Optionee’s status as an employee shall terminate for any reason other than Optionee’s disability or death, then Optionee (or if the Optionee shall die after such termination, but prior to exercise, Optionee’s personal representative or the person entitled to succeed to the Option) shall have the right to exercise the portions of any of Optionee’s Incentive Stock Options which were exercisable as of the date of such termination, in whole or in part, not less than 30 days nor more than three (3) months after such termination (or, in the event of “ termination for Cause ”, the Option shall automatically terminate as of the termination of employment as to all shares covered by the Option).
|
(f) |
Disability of Optionee: If an Optionee is disabled (within the meaning of Section 22(e)(3) of the Code) at the time of termination, the three (3) month period set forth in Section 5(e) shall be a period, as determined by the Board and set forth in the Option, of not less than six months nor more than one year after such termination.
|
(g) |
Death of Optionee: If an Optionee dies while employed by, engaged as a consultant to, or serving as a Director of the Company, the portion of such Optionee’s Option which was exercisable at the date of death may be exercised, in whole or in part, by the estate of the decedent or by a person succeeding to the right to exercise such Option at any time within (i) a period, as determined by the Board and set forth in the Option, of not less than six (6) months nor more than one (1) year after Optionee’s death, which period shall not be more, in the case of a Nonstatutory Option, than the period for exercise following termination of employment or services, or (ii) during the remaining term of the Option, whichever is the lesser. The Option may be so exercised only with respect to installments exercisable at the time of Optionee’s death and not previously exercised by the Optionee.
|
(h) |
Nontransferability of Option: No Option shall be transferable by the Optionee, except by will or by the laws of descent and distribution.
|
(i) |
Recapitalization: Subject to any required action of shareholders, the number of shares of Stock covered by each outstanding Option, and the exercise price per share thereof set forth in each such Option, shall be proportionately adjusted for any increase or decrease in the number of issued shares of Stock of the Company resulting from a stock split, stock dividend, combination, subdivision or reclassification of shares, or the payment of a stock dividend, or any other increase or decrease in the number of such shares affected without receipt of consideration by the Company; provided, however, the conversion of any convertible securities of the Company shall not be deemed to have been “ effected without receipt of consideration ” by the Company.
|
(j) |
Rights as a Shareholder: An Optionee shall have no rights as a shareholder with respect to any shares covered by an Option until the effective date of the issuance of the shares following exercise of such Option by Optionee. No adjustment shall be made for dividends (ordinary or extraordinary, whether in cash, securities or other property) or distributions or other rights for which the record date is prior to the date such stock certificate is issued, except as expressly provided in Section 5(i) hereof.
|
(k) |
Modification, Acceleration, Extension, and Renewal of Options: Subject to the terms and conditions and within the limitations of the Plan, the Board may modify an Option, or, once an Option is exercisable, accelerate the rate at which it may be exercised, and may extend or renew outstanding Options granted under the Plan or accept the surrender of outstanding Options (to the extent not theretofore exercised) and authorize the granting of new Options in substitution for such Options, provided such action is permissible under Section 422 of the Code and applicable state securities rules. Notwithstanding the provisions of this Section 5(k), however, no modification of an Option shall, without the consent of the Optionee, alter to the Optionee’s detriment or impair any rights or obligations under any Option theretofore granted under the Plan.
|
(l) |
Exercise Before Exercise Date: At the discretion of the Board, the Option may, but need not, include a provision whereby the Optionee may elect to exercise all or any portion of the Option prior to the stated exercise date of the Option or any installment thereof. Any shares so purchased prior to the stated exercise date shall be subject to repurchase by the Company upon termination of Optionee’s employment as contemplated by Section 5(n) hereof prior to the exercise date stated in the Option and such other restrictions and conditions as the Board or Committee may deem advisable.
|
(m) |
Other Provisions: The Option agreements authorized under the Plan shall contain such other provisions, including, without limitation, restrictions upon the exercise of the Options, as the Board or the Committee shall deem advisable. Shares shall not be issued pursuant to the exercise of an Option, if the exercise of such Option or the issuance of shares thereunder would violate, in the opinion of legal counsel for the Company, the provisions of any applicable law or the rules or regulations of any applicable governmental or administrative agency or body, such as the Code, the Securities Act, the Exchange Act, applicable state securities rules, Nevada corporation law, and the rules promulgated under the foregoing or the rules and regulations of any exchange upon which the shares of the Company are listed. Without limiting the generality of the foregoing, the exercise of each Option shall be subject to the condition that if at any time the Company shall determine that (i) the satisfaction of withholding tax or other similar liabilities, or (ii) the listing, registration or qualification of any shares covered by such exercise upon any securities exchange or under any state or federal law, or (iii) the consent or approval of any regulatory body, or (iv) the perfection of any exemption from any such withholding, listing, registration, qualification, consent or approval is necessary or desirable in connection with such exercise or the issuance of shares thereunder, then in any such event, such exercise shall not be effective unless such withholding, listing registration, qualification, consent, approval or exemption shall have been effected, obtained or perfected free of any conditions not acceptable to the Company.
|
(n) |
Repurchase Agreement: The Board may, in its discretion, require as a condition to the Grant of an Option hereunder, that an Optionee execute an agreement with the Company, pursuant to forms which shall be approved by the Board of Directors from time to time (“ Repurchase Agreement ”), (i) restricting the Optionee’s right to transfer shares purchased under such Option without first offering such shares to the Company or another shareholder of the Company upon the same terms and conditions as provided therein; and (ii) providing that upon termination of Optionee’s employment with the Company, for any reason, the Company (or another shareholder of the Company, as provided in the Repurchase Agreement) shall have the right at its discretion (or the discretion of such other shareholders) to purchase and/or redeem all such shares owned by the Optionee on the date of termination of his or her employment at a price equal to: (A) the fair value of such shares as of such date of termination; or (B) if such repurchase right lapses at 20% of the number of shares per year, the original purchase price of such shares, and upon terms of payment permissible under applicable state securities rules; provided that in the case of Options or Stock Awards granted to officers, directors, consultants or affiliates of the Company, such repurchase provisions may be subject to additional or greater restrictions as determined by the Board or Committee.
|
6. | Stock Awards and Restricted Stock Purchase Offers. |
(a) | Types of Grants. |
(i) |
Stock Award. All or part of any Stock Award under the Plan may be subject to conditions established by the Board or the Committee, and set forth in the Stock Award Agreement, which may include, but are not limited to, continuous service with the Company, achievement of specific business objectives, increases in specified indices, attaining growth rates and other comparable measurements of Company performance. Such Awards may be based on Fair Market Value or other specified valuation. All Stock Awards will be made pursuant to the execution of a Stock Award Agreement pursuant to forms which shall be approved by the Board of Directors from time to time.
|
(ii) |
Restricted Stock Purchase Offer. A Grant of a Restricted Stock Purchase Offer under the Plan shall be subject to such (i) vesting contingencies related to the Participant’s continued association with the Company for a specified time and (ii) other specified conditions as the Board or Committee shall determine, in their sole discretion, consistent with the provisions of the Plan. All Restricted Stock Purchase Offers shall be made pursuant to a Restricted Stock Purchase Offer pursuant to forms which shall be approved by the Board of Directors from time to time.
|
(b) |
Conditions and Restrictions. Shares of Stock which Participants may receive as a Stock Award under a Stock Award Agreement or Restricted Stock Purchase Offer under a Restricted Stock Purchase Offer may include such restrictions as the Board or Committee, as applicable, shall determine, including restrictions on transfer, repurchase rights, right of first refusal, and forfeiture provisions. When transfer of Stock is so restricted or subject to forfeiture provisions it is referred to as “ Restricted Stock ”. Further, with Board or Committee approval, Stock Awards or Restricted Stock Purchase Offers may be deferred, either in the form of installments or a future lump sum distribution. The Board or Committee may permit selected Participants to elect to defer distributions of Stock Awards or Restricted Stock Purchase Offers in accordance with procedures established by the Board or Committee to assure that such deferrals comply with applicable requirements of the Code including, at the choice of Participants, the capability to make further deferrals for distribution after retirement. Any deferred distribution, whether elected by the Participant or specified by the Stock Award Agreement, Restricted Stock Purchase Offers or by the Board or Committee, may require the payment be forfeited. Dividends or dividend equivalent rights may be extended to and made part of any Stock Award or Restricted Stock Purchase Offers denominated in Stock or units of Stock, subject to such terms, conditions and restrictions as the Board or Committee may establish.
|
(c) | Intentionally left blank. |
(d) | Nonassignability. |
(i) | Except pursuant to Section 6(e)(iii) and except as set forth in Section 6(d)(ii), no Grant or any other benefit under the Plan shall be assignable or transferable, or payable to or exercisable by, anyone other than the Participant to whom it was granted. |
(ii) | Where a Participant terminates employment and retains a Grant pursuant to Section 6(e)(ii) in order to assume a position with a governmental, charitable or educational institution, the Board or Committee, in its discretion and to the extent permitted by law, may authorize a third party (including but not limited to the trustee of a “blind” trust), acceptable to the applicable governmental or institutional authorities, the Participant and the Board or Committee, to act on behalf of the Participant with regard to such Awards. |
(e) |
Termination of Employment. If the employment or service to the Company of a Participant terminates, other than pursuant to any of the following provisions under this Section 6(e), all unexercised, deferred and unpaid Stock Awards or Restricted Stock Purchase Offers shall be cancelled immediately, unless the Stock Award Agreement or Restricted Stock Purchase Offer provides otherwise:
|
(i) |
Retirement Under a Company Retirement Plan. When a Participant’s employment terminates as a result of retirement , the Board or Committee may permit Stock Awards or Restricted Stock Purchase Offers to continue in effect beyond the date of retirement in accordance with the applicable Grant Agreement and the exercisability and vesting of any such Grants may be accelerated.
|
(ii) |
Rights in the Best Interests of the Company. When a Participant resigns from the Company and, in the judgment of the Board or Committee, the acceleration and/or continuation of outstanding Stock Awards or Restricted Stock Purchase Offers would be in the best interests of the Company, the Board or Committee may (i) authorize, where appropriate, the acceleration and/or continuation of all or any part of Grants issued prior to such termination and (ii) permit the exercise, vesting and payment of such Grants for such period as may be set forth in the applicable Grant Agreement, subject to earlier cancellation pursuant to Section 9 or at such time as the Board or Committee shall deem the continuation of all or any part of the Participant’s Grants are not in the Company’s best interest.
|
(iii) | Death or Disability of a Participant. |
(1) | In the event of a Participant’s death, the Participant’s estate or beneficiaries shall have a period up to the expiration date specified in the Grant Agreement within which to receive or exercise any outstanding Grant held by the Participant under such terms as may be specified in the applicable Grant Agreement. Rights to any such outstanding Grants shall pass by will or the laws of descent and distribution in the following order: (a) to beneficiaries so designated by the Participant; if none, then (b) to a legal representative of the Participant; if none, then (c) to the persons entitled thereto as determined by a court of competent jurisdiction. Grants so passing shall be made at such times and in such manner as if the Participant were living. |
(2) | In the event a Participant is deemed by the Board or Committee to be unable to perform his or her usual duties by reason of mental disorder or medical condition which does not result from facts which would be grounds for termination for cause, Grants and rights to any such Grants may be paid to or exercised by the Participant, if legally competent, or a committee or other legally designated guardian or representative if the Participant is legally incompetent by virtue of such disability. |
(3) | After the death or disability of a Participant, the Board or Committee may in its sole discretion at any time (1) terminate restrictions in Grant Agreements; (2) accelerate any or all installments and rights; and (3) instruct the Company to pay the total of any accelerated payments in a lump sum to the Participant, the Participant’s estate, beneficiaries or representative; notwithstanding that, in the absence of such termination of restrictions or acceleration of payments, any or all of the payments due under the Grant might ultimately have become payable to other beneficiaries. |
(4) | In the event of uncertainty as to interpretation of or controversies concerning this Section 6, the determinations of the Board or Committee, as applicable, shall be binding and conclusive. |
7. | Investment Intent. All Grants under the Plan are intended to be exempt from registration under the Securities Act provided by Rule 701 thereunder. Unless and until the granting of Options or sale and issuance of Stock subject to the Plan are registered under the Securities Act or shall be exempt pursuant to the rules promulgated thereunder, each Grant under the Plan shall provide that the purchases or other acquisitions of Stock thereunder shall be for investment purposes and not with a view to, or for resale in connection with, any distribution thereof. Further, unless the issuance and sale of the Stock have been registered under the Securities Act, each Grant shall provide that no shares shall be purchased upon the exercise of the rights under such Grant unless and until (i) all then applicable requirements of state and federal laws and regulatory agencies shall have been fully complied with to the satisfaction of the Company and its counsel, and (ii) if requested to do so by the Company, the person exercising the rights under the Grant shall (i) give written assurances as to knowledge and experience of such person (or a representative employed by such person) in financial and business matters and the ability of such person (or representative) to evaluate the merits and risks of exercising the Option, and (ii) execute and deliver to the Company a letter of investment intent and/or such other form related to applicable exemptions from registration, all in such form and substance as the Company may require. If shares are issued upon exercise of any rights under a Grant without registration under the Securities Act, subsequent registration of such shares shall relieve the purchaser thereof of any investment restrictions or representations made upon the exercise of such rights. |
8. | Amendment, Modification, Suspension or Discontinuance of the Plan. The Board may, insofar as permitted by law, from time to time, with respect to any shares at the time not subject to outstanding Grants, suspend or terminate the Plan or revise or amend it in any respect whatsoever, except that without the approval of the shareholders of the Company, no such revision or amendment shall (i) increase the number of shares subject to the Plan, (ii) decrease the price at which Grants may be granted, (iii) materially increase the benefits to Participants, or (iv) change the class of persons eligible to receive Grants under the Plan; provided, however, no such action shall alter or impair the rights and obligations under any Option, or Stock Award, or Restricted Stock Purchase Offer outstanding as of the date thereof without the written consent of the Participant thereunder. No Grant may be issued while the Plan is suspended or after it is terminated, but the rights and obligations under any Grant issued while the Plan is in effect shall not be impaired by suspension or termination of the Plan. |
9. | Tax Withholding. The Company shall have the right to deduct applicable taxes from any Grant payment and withhold, at the time of delivery or exercise of Options, Stock Awards or Restricted Stock Purchase Offers or vesting of shares under such Grants, an appropriate number of shares for payment of taxes required by law or to take such other action as may be necessary in the opinion of the Company to satisfy all obligations for withholding of such taxes. If Stock is used to satisfy tax withholding, such stock shall be valued based on the Fair Market Value when the tax withholding is required to be made. |
10. | Intentionally Left Blank. |
11. | Notice. Any written notice to the Company required by any of the provisions of the Plan shall be addressed to the chief financial officer or to the chief executive officer of the Company and shall become effective when it is received by the office of the chief personnel officer or the chief executive officer. |
12. | Indemnification of Board. In addition to such other rights or indemnifications as they may have as directors or otherwise, and to the extent allowed by applicable law, the members of the Board and the Committee shall be indemnified by the Company against the reasonable expenses, including attorneys’ fees, actually and necessarily incurred in connection with the defense of any claim, action, suit or proceeding, or in connection with any appeal thereof, to which they or any of them may be a party by reason of any action taken, or failure to act, under or in connection with the Plan or any Grant granted thereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved by independent legal counsel selected by the Company) or paid by them in satisfaction of a judgment in any such claim, action, suit or proceeding, except in any case in relation to matters as to which it shall be adjudged in such claim, action, suit or proceeding that such Board or Committee member is liable for negligence or misconduct in the performance of his or her duties; provided that within sixty (60) days after institution of any such action, suit or Board proceeding the member involved shall offer the Company, in writing, the opportunity, at its own expense, to handle and defend the same. |
13. | Governing Law. The Plan and all determinations made and actions taken pursuant hereto, to the extent not otherwise governed by the Code or the securities laws of the United States, shall be governed by the law of the State of Nevada and construed accordingly. |
14. | Effective and Termination Dates. The Plan shall become effective on the date it is approved by the holders of a majority of the shares of Stock then outstanding. The Plan shall terminate ten years later, subject to earlier termination by the Board pursuant to Section 8. |